Table 2. Vaccine allocation strategies obtained by FluTe+MADS and SEIR+MADS under the base-case scenario.
| Performance measure | Vaccination fractions for each age group | |||||
|---|---|---|---|---|---|---|
| 0–4 | 5–18 | 19–29 | 30–64 | 65+ | ||
| TC | SEIR+MADS | - | 87% | - | - | - |
| FluTe+MADS | - | 99% | 34% | - | - | |
| TI | SEIR+MADS | 100% | 100% | 9% | - | - |
| FluTe+MADS | 89% | 100% | 9% | 1% | 1% | |
| TD | SEIR+MADS | 100% | 100% | 9% | - | - |
| FluTe+MADS | 5% | 97% | 50% | 3% | 2% | |
| TY | SEIR+MADS | 100% | 100% | 9% | - | - |
| FluTe+MADS | 21% | 98% | 50% | 1% | - | |
R0 = 1.6, 30% vaccine coverage, no delay in response time. TC: Total cost, TI: Total number of infections, TD: Total number of deaths, TY: Total YLL